https://www.thebodypro.com/category/adverse-events-comorbidities-hiv/tag/sexually-transmitted-infections
Adverse Events, Comorbidities, and HIV

Sexually Transmitted Infections

The Latest

virology

This Week in HIV Research: Is Viral Suppression an STI Prevention Tool?

March 5, 2020: How U=U reduces more than HIV transmission; "other" HPV strain risks post-vaccination; vitamin E for nonalcoholic steatohepatitis; HCV therapy and increased cardiovascular risk.

By Barbara Jungwirth and Myles Helfand
hand reaching

This Week in HIV Research: Where Our Reach Falls Short

Dec. 19, 2019: Often-insufficient CD4 and viral load testing for women; factors affecting syphilis incidence among women with HIV; STI testing rates among people with HIV; the effect of benzodiazepines on neurocognition.

By Barbara Jungwirth and Myles Helfand
Doxycycline for STIs photo illo

Doxycycline for Bacterial STI Prevention: A Different Type of PrEP

An international team of experts conducted a thoughtful review of existing research regarding the use of doxycycline for STI prevention. Do the risks of its use outweigh the benefits?

By David Alain Wohl, M.D.
doctor giving young person vaccine

HPV Vaccine Rates Are Low Because People Still Don't Understand Its Cancer Risks

The vaccine for human papillomavirus got a bad rap when it debuted. And yet time has shown it's very effective in reducing cancers linked to HPV.

By Martha Kempner
Various Road Closed signs

Test-and-Treat for Hepatitis C: What Are the Obstacles?

A series of studies aim to determine whether test-and-treat strategies can be implemented for people with hepatitis C, much like programs for people living with HIV.

By Sony Salzman
people in a doctor's office waiting room

This Week in HIV Research: The Reality of Disparity

Sept. 26, 2019: Racial disparities in the PrEP continuum; HIV and ocular syphilis; Kaposi sarcoma among people with well-suppressed HIV; modifiable risk factors in the management of chronic kidney disease.

By Barbara Jungwirth and Myles Helfand
doctor's gloved hands putting cotton swab test into sterile tube

HPV Rates Similar Among Gay and Bisexual Men and Cisgender Women

A new study adds to mounting evidence that all people should be screened and offered the vaccine for human papillomavirus.

By Martha Kempner
Ivana Beesham

Experts Flummoxed By Conflicting New Data on STIs, HIV, and Long-Term Contraception in Sub-Saharan Africa

ECHO trial results and follow-up studies find unexpectedly low rates of some STIs among users of certain long-term hormonal contraceptives. They also find high HIV rates (unrelated to the contraceptives) that suggest considerable value for PrEP integration.

By Sony Salzman
couple on the boardwalk surrounded by seagulls

This Week in HIV Research: When STIs Flock Together

July 18, 2019: Anal neoplasia risk amidst comorbid HPV and chlamydia; predictive modeling for PrEP outreach; long-term benefits of hepatitis C cure in coinfection; first-line therapy with dolutegravir/lamivudine.

By Barbara Jungwirth and Myles Helfand
Anchor on edge of boat

This Week in HIV Research: Weighing Anchor on NRTI-Free Treatment

June 27, 2019: Long-term viability of NRTI-free salvage therapy; factors associated with HIV treatment interruption; evolution of frailty risk among older people; skin and soft tissue infections among people with HIV.

By Barbara Jungwirth and Myles Helfand